Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

23 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Recruiting

Study of HLD-0915 in Patients With Metastatic Prostate Cancer

NCT06800313

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale - New Haven Hospital - Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib

NCT04676334

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +29 more
Locations
  • London Regional Cancer Centre London, Ontario, Canada
  • Institut De Recherche De L'Hospital D'Ottawa Ottawa, Ontario, Canada
  • Princess Margaret Hospital - Toronto Toronto, Ontario, Canada
  • Centre Hospitalier de L'Universite de Montreal (CHUM) Montreal, Quebec, Canada
View all 25 locations
View Trial Details
Completed

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

NCT00946881

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • UCLA - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Midtown Urology & Midtown Urology Surgical Center Atlanta, Georgia, United States
  • Washington University School of Medicine- Barnes-Jewish Hospital St Louis, Missouri, United States
  • NYU Urology Associates New York, United States
View Trial Details
Completed

A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study

NCT02578797

Conditions
Castration-resistant Prostate Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Greenville, South Carolina, United States
  • Montreal, Quebec, Canada
  • Chisinau, Moldova
  • Rotterdam, Netherlands
View Trial Details
Completed

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)

NCT03490032

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations
  • Pheonix Molecular Imaging Center Phoenix, Arizona, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Smilow Cancer Center at Yale New Haven New Haven, Connecticut, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details

Related conditions